 Solubility
"Solubility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
| Descriptor ID |
D012995
|
| MeSH Number(s) |
G02.842.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Solubility".
Below are MeSH descriptors whose meaning is more specific than "Solubility".
This graph shows the total number of publications written about "Solubility" by people in UAMS Profiles by year, and whether "Solubility" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 1 | 3 | | 2022 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2016 | 0 | 2 | 2 | | 2015 | 0 | 2 | 2 | | 2013 | 0 | 3 | 3 | | 2011 | 0 | 1 | 1 | | 2010 | 0 | 7 | 7 | | 2009 | 0 | 5 | 5 | | 2008 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2006 | 0 | 4 | 4 | | 2005 | 0 | 3 | 3 | | 2004 | 0 | 6 | 6 | | 2003 | 0 | 2 | 2 | | 2002 | 0 | 2 | 2 | | 1996 | 0 | 1 | 1 | | 1990 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Solubility" by people in Profiles over the past ten years.
-
Song J, Bao R, Lin M, Li W, Zhao P, Liu X, Fu Q. Investigation of the dissolution rate and oral bioavailability of atenolol-irbesartan co-amorphous systems. Int J Pharm. 2024 Nov 15; 665:124704.
-
Waldrip ZJ, Acharya B, Armstrong D, Hanafi M, Rainwater RR, Amole S, Fulmer M, Azevedo-Pouly AC, Burns A, Burdine L, Frett B, Burdine MS. Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441. Sci Rep. 2024 08 28; 14(1):19999.
-
Khare S, Jog R, Bright A, Burgess DJ, Chakder SK, Gokulan K. Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats. Nanotoxicology. 2023 Dec; 17(10):583-603.
-
Imig JD. Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD. Kidney360. 2022 09 29; 3(9):1477-1479.
-
Imig JD, Cervenka L, Neckar J. Epoxylipids and soluble epoxide hydrolase in heart diseases. Biochem Pharmacol. 2022 01; 195:114866.
-
Thoene MK, Van Ormer MC, Lyden ER, Thompson MK, Yuil-Valdes AG, Natarajan SK, Mukherjee MS, Nordgren TM, Furtado JD, Anderson-Berry AL, Hanson CK, Snowden JN. Concentrations of fat-soluble nutrients and blood inflammatory compounds in mother-infant dyads at birth. Pediatr Res. 2021 08; 90(2):436-443.
-
Edwards JS, Hettiarachchy NS, Kumar TKS, Carbonero F, Martin EM, Benamara M. Physicochemical properties of soy protein hydrolysate and its formulation and stability with encapsulated probiotic under?in?vitro?gastrointestinal environment. J Food Sci. 2020 Oct; 85(10):3543-3551.
-
Arroyo E, Wells AJ, Gordon JA, Varanoske AN, Gepner Y, Coker NA, Church DD, Fukuda DH, Stout JR, Hoffman JR. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise. Exp Gerontol. 2017 12 15; 100:28-35.
-
Norman SE, Turner AH, Holbrey JD, Youngs TG. Solvation Structure of Uracil in Ionic Liquids. Chemphyschem. 2016 Dec 05; 17(23):3923-3931.
-
Ayyadevara S, Balasubramaniam M, Parcon PA, Barger SW, Griffin WS, Alla R, Tackett AJ, Mackintosh SG, Petricoin E, Zhou W, Shmookler Reis RJ. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls. Aging Cell. 2016 10; 15(5):924-39.
-
Zhang X, Tang K, Wang H, Liu Y, Bao B, Fang Y, Zhang X, Lu W. Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker. Bioconjug Chem. 2016 05 18; 27(5):1267-75.
-
Jambhekar SS, Breen P. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency. Drug Discov Today. 2016 Feb; 21(2):363-8.
-
Ye H, Tanenbaum LM, Na YJ, Mantzavinou A, Fulci G, Del Carmen MG, Birrer MJ, Cima MJ. Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models. J Control Release. 2015 Dec 28; 220(Pt A):358-367.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|